Literature DB >> 17407311

Breast cancer prevention by green tea catechins and black tea theaflavins in the C3(1) SV40 T,t antigen transgenic mouse model is accompanied by increased apoptosis and a decrease in oxidative DNA adducts.

Siminder Kaur1, Peter Greaves, Darren N Cooke, Richard Edwards, William P Steward, Andreas J Gescher, Timothy H Marczylo.   

Abstract

Tea consumption is associated with a reduced risk of mammary cancer as reflected by epidemiological studies and experiments in carcinogen-induced rodent models of mammary carcinogenesis. We tested the hypothesis that green tea catechins (GTC) or theaflavins from black tea (BTT) interfere with mammary carcinogenesis in C3(1) SV40 T,t antigen transgenic multiple mammary adenocarcinoma (TAg) mice and that GTC/BTT affect tumor survival or oxidation status. TAg mice received GTC/BTT (0.05%) in drinking water for their lifetime. As compared to control mice, they survived longer and had smaller tumors. On microscopic inspection, the size of the largest tumor per mouse was decreased by 40-42% (p<0.01). GTC (0.01%) and BTT (0.05%) increased levels of cleaved caspase 3 in tumor tissue by 67 and 38%, respectively (p<0.05), intimating increased apoptosis. Tumor levels of the malondialdehyde-DNA adduct M1dG in mice receiving GTC or BTT (0.05%) were reduced by 78 (p<0.001) or 63% (p<0.05), respectively, as compared to controls. The results render the exploration of the breast cancer chemopreventive properties of tea preparations in humans worthwhile.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17407311     DOI: 10.1021/jf0633342

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  22 in total

Review 1.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

Review 2.  Green tea compounds in breast cancer prevention and treatment.

Authors:  Min-Jing Li; Yan-Cun Yin; Jiao Wang; Yang-Fu Jiang
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  Going Green: The Role of the Green Tea Component EGCG in Chemoprevention.

Authors:  Laura Schramm
Journal:  J Carcinog Mutagen       Date:  2013-05-20

Review 4.  Green tea and breast cancer.

Authors:  Anna H Wu; Lesley M Butler
Journal:  Mol Nutr Food Res       Date:  2011-04-29       Impact factor: 5.914

5.  Structural identification of mouse fecal metabolites of theaflavin 3,3'-digallate using liquid chromatography tandem mass spectrometry.

Authors:  Huadong Chen; Tiffany A Parks; Xiaoxin Chen; Nicholas D Gillitt; Christian Jobin; Shengmin Sang
Journal:  J Chromatogr A       Date:  2011-08-25       Impact factor: 4.759

Review 6.  The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention.

Authors:  Joshua D Lambert; Ryan J Elias
Journal:  Arch Biochem Biophys       Date:  2010-06-15       Impact factor: 4.013

7.  Drinking green tea modestly reduces breast cancer risk.

Authors:  Martha J Shrubsole; Wei Lu; Zhi Chen; Xiao Ou Shu; Ying Zheng; Qi Dai; Qiuyin Cai; Kai Gu; Zhi Xian Ruan; Yu-Tang Gao; Wei Zheng
Journal:  J Nutr       Date:  2008-12-11       Impact factor: 4.798

Review 8.  Antioxidative and anti-carcinogenic activities of tea polyphenols.

Authors:  Chung S Yang; Joshua D Lambert; Shengmin Sang
Journal:  Arch Toxicol       Date:  2008-11-12       Impact factor: 5.153

Review 9.  Polyphenols delivery by polymeric materials: challenges in cancer treatment.

Authors:  Orazio Vittorio; Manuela Curcio; Monica Cojoc; Gerardo F Goya; Silke Hampel; Francesca Iemma; Anna Dubrovska; Giuseppe Cirillo
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Magnetic resonance imaging of the natural history of in situ mammary neoplasia in transgenic mice: a pilot study.

Authors:  Sanaz A Jansen; Suzanne D Conzen; Xiaobing Fan; Erica J Markiewicz; Gillian M Newstead; Gregory S Karczmar
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.